Dr. Daniel Alfson, MD

Dr. Alfson practices at Surgery Associates of Ntx in Denton, Texas.

Dr. Alfson's NPI, 1255713780, was assigned on June 21, 2015. Dr. Alfson graduated from UTMB Health in 2013. Dr. Alfson's Texas license number on file is U7825.

Dr. Alfson's primary practice is Surgery Associates of Ntx, at 3322 Colorado Blvd, Denton, TX 76210 in Denton County. The practice phone is (940) 387-7588.

Dr. Alfson's primary practice is Surgery Associates of Ntx in Denton, Texas. Dr. Alfson is also affiliated with Medical City Dallas Hospital. The medical group on file is Surgery Associates of North Texas. Dmand AI also links Dr. Alfson to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alfson practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Alfson's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Alfson is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Alfson's licenses on file in 3 states: Texas, California and Massachusetts.

Dmand AI lists amputation, aortic atherosclerois, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, circulatory problems in extremities and deep vein thrombosis (DVT) among the conditions Dr. Alfson treats.

CMS data shows 577 Medicare services from Dr. Alfson across 20 procedure codes in 2024, for 230 Medicare patients. Medicare paid $48,460 for them.

CMS counts 230 Medicare patients who saw Dr. Alfson in 2024. The largest group is 75 to 84, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alfson's median patient age at 70, with 45% women.

In 2024, Dr. Alfson wrote 73 Medicare Part D claims for 34 patients. 47% of them were for generic drugs. CMS names the drug for 34 of them, across 1 drug with 11 or more claims each, at $30,424 in total drug cost. In 2023, CMS named 81 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Alfson for performance year 2024, reported as part of a group. Dr. Alfson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 17 procedures of leg revascularization (restoring blood flow) by Dr. Alfson, more than 76% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Alfson, published from 2017 to 2022. 2020 was the busiest year, with 3. The most frequent topics are Blood Vessel Prosthesis Implantation and Endovascular Procedures. Dr. Alfson's most frequent co-authors are Demetrios Demetriades, MD, Hassan Aziz, MD and Sung Wan Ham, MD.

CMS Open Payments shows 99 general payments to Dr. Alfson from 27 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 84% of the total. W. L. Gore & Associates, Inc. paid the most, $1,131.

Dr. Alfson graduated from UTMB Health in 2013.

Dr. Alfson is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.